Multiple Sclerosis

Q&A With Tanuja Chitnis, MD, from Brigham and Women's Hospital: Treating Multiple Sclerosis in Women and Through Life Changes

Studies of multiple sclerosis have shown that men are more severely affected by the condition and that relapse recovery can also be worse in men. While there continues to be research on the topic it is believed that testosterone can play a role.

Genetic Influence on MS Disability: Look for Spinal Cord Gray Matter Atrophy on MRI

Treating a condition like multiple sclerosis presents a number of problems for patients and healthcare professionals alike. Those challenges can change and develop over a patient's lifetime as well.

By Linda G. Hughes, MA

Final Thoughts and Conclusions on Multiple Sclerosis

Research on spinal cord gray matter atrophy in terms of progressive multiple sclerosis has found the highest correlations between disability and gray matter volume loss within the spinal cord.

Multiple Sclerosis Incidence Is Rising

Osteoporosis and Multiple Sclerosis

The Potential for Neuronal Repair in Multiple Sclerosis

Treating Multiple Sclerosis When Copaxone Goes Generic

Factors to Consider When Discontinuing MS Treatment

Lifestyle Modifications for Patients with Multiple Sclerosis

Talking to Patients about Their Multiple Sclerosis

Multiple Sclerosis Treatment Algorithms

Oral Therapies for Multiple Sclerosis

Alemtuzumab Efficacy and Safety for Multiple Sclerosis

Pegylated Interferon Beta-1a for Multiple Sclerosis

New Medications for Multiple Sclerosis

Pregnancy and Smoking in Multiple Sclerosis

The Association Between MS and Coronary Artery Disease

Multiple Sclerosis, Vitamin D, and the Microbiome

Vitamin D and the Course of Disease in Multiple Sclerosis

Toward a Deeper Understanding of Multiple Sclerosis Pathophysiology

Q&A With Bruce Trapp, PhD From the Cleveland Clinic: Digging Deeper Into Progressive Multiple Sclerosis

Q&A With Maureen Mealy, RN, from Johns Hopkins: Neuromyelitis Optica and Multiple Sclerosis Differences Matter in Diagnosis and Treatment

More may be known about the relapsing form of multiple sclerosis but researchers are working to learn about the progressive form of the disease as well. That includes looking for potential tools to stop neurological degeneration from harming patients.

Q&A With Jack Burks of the Multiple Sclerosis Association of America: Addressing Patient Concerns in Multiple Sclerosis Relapses

The symptoms of neuromyelitis optica and multiple sclerosis may appear similar at first glance but an improper diagnosis can create more issues for patients than they originally experienced.

Q&A With Jack Burks of the Multiple Sclerosis Association of America: Keeping Communication Open in Treatment of Multiple Sclerosis Relapses

Patients with multiple sclerosis face a variety of challenges in their daily lives, especially when they experience a relapse. How they and their healthcare professionals approach these relapses can impact their overall quality of life even after the relapse passes.

Q&A With Stacey Cofield, PhD, From University of Alabama at Birmingham: Study Shows Benefits of Marijuana in Multiple Sclerosis Needs More Research

Multiple sclerosis is a condition that affects a person's life over the course of many years. For those with the relapsing form that can include managing symptoms and potential relapses that come during treatment.

Q&A With Stacey Cofield, PhD, From University of Alabama at Birmingham: NARCOMS Survey Takes Closer Look at Marijuana Use Among Patients with Multiple Sclerosis

Medical marijuana has shown some benefits in the treatment of other health conditions, but its efficacy for patients with multiple sclerosis is still to be determined.

Weighing Risks and Rewards with Alemtuzumab in Patients with Multiple Sclerosis

The issue of marijuana use is complicated for many reasons. One of the biggest, according to a recent survey is the willingness of patients and healthcare providers alike to even discuss the topic.

By Linda G. Hughes, MA

Treatment with Alemtuzumab Might Be â€˜Resetting' the Immune System in Patients with Relapsing-Remitting Multiple Sclerosis

Alemtuzumab has been shown in clinical trials to be more effective than treatment with interferon beta-1a for patients with relapsing-remitting multiple sclerosis. However, the drug's side effect profile requires careful treatment monitoring and follow up.

By Linda G. Hughes, MA

Q&A With Lacey Bromley From the University of Buffalo: Balancing Physical Therapy in Multiple Sclerosis Patients with Movement Disorders

Study results indicate that treatment with alemtuzumab reduces focal inflammation, with durable effects that may be due to the distinct pattern of lymphocyte depletion and repopulation after treatment.